Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-07-20
Original market date: See footnote 1
1997-09-11
Product name:
ERYTHROMYCIN
DIN:
02141574
Product Monograph/Veterinary Labelling:
Date:
2020-07-21
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PHARMA STULLN INC.
6500 Trans Canada Highway, Suite 400
Pointe-Claire
Quebec
Canada
H9R 0A5
Class:
Human
Dosage form(s):
Ointment
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:04.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01AA17 ERYTHROMYCIN
Active ingredient group (AIG) number:See footnote5
0105708001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ERYTHROMYCIN | 5 MG / G |